Symlin

Pramlintide

Pramlintide (trade name Symlin) is an injectable amylin analogue drug for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca).[1] Pramlintide is sold as an acetate salt. Contents 1 Pharmacology 2 Approval 3 Design and structure 4 References 5 External links Pharmacology Pramlintide is an analogue of amylin, a small peptide hormone that is released into the bloodstream by the β cells of the pancreas along ...

Drug Index

Pramlintide (trade name Symlin) is an injectable amylin analogue drug for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca).[1] Pramlintide is sold as an acetate salt. Contents 1 Pharmacology 2 Approval 3 Design and structure 4 References 5 External links Pharmacology Pramlintide is an analogue of amylin, a small peptide hormone that is released into the bloodstream by the β cells of the pancreas along ...

to lower blood sugar

Symlin (pramlintide acetate) injection 0.6mg/ml. 5ml.VGial

I'd like to chat with others who are taking symlin along with insulin

NDC Database

Symlinpen 1000 ug/ml Subcutaneous Injection by Astrazeneca Pharmaceuticals Lp ## Package Codes: 0310-6615-02 ## Active Ingredients: Pramlintide Acetate

NDC Database

Symlinpen 1000 ug/ml Subcutaneous Injection by Astrazeneca Pharmaceuticals Lp ## Package Codes: 0310-6627-02 ## Active Ingredients: Pramlintide Acetate

NDC Database

Symlin 600 ug/ml Subcutaneous Injection by Amylin Pharmaceuticals, Inc. ## Package Codes: 66780-110-01, 66780-110-04 ## Active Ingredients: Pramlintide Acetate

NDC Database

Symlinpen 1000 ug/ml Subcutaneous Injection by Amylin Pharmaceuticals, Inc. ## Package Codes: 66780-115-01, 66780-115-02 ## Active Ingredients: Pramlintide Acetate

NDC Database

Symlinpen 1000 ug/ml Subcutaneous Injection by Amylin Pharmaceuticals, Inc. ## Package Codes: 66780-121-01, 66780-121-02 ## Active Ingredients: Pramlintide Acetate